The 2026 regulatory changes opened a path toward licensed compounding access in the United States, but the FDA's Pharmacy Compounding Advisory Committee decision in July 2026 will determine whether that path expands or narrows
The SURMOUNT-1 trial demonstrated up to 22.5% body weight reduction with tirzepatide at the highest dose (15mg weekly), compared to semaglutide's 14.9% in STEP 1
Place the Self-Injector over a fatty tissue area on the body (stomach, arm or thighs) and then gently press the one-touch button on the Self-Injector and within seconds you will be feeling refreshed and energized.
If your diet includes no or little amounts of these foods, make sure you get your B12 from alternative sources since a B12 deficiency could actually work against you in your effort to lose weight
This is the most widely used ratio because it creates manageable volumes for common dose ranges
I wish you well Well done Clivealive, you should be eligible for some award putting in 50 years of this